First Time Loading...
S

Santhera Pharmaceuticals Holding AG
SIX:SANN

Watchlist Manager
Santhera Pharmaceuticals Holding AG
SIX:SANN
Watchlist
Price: 9.33 CHF -0.43%
Updated: May 3, 2024

Santhera Pharmaceuticals Holding AG
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santhera Pharmaceuticals Holding AG
Cash from Operating Activities Peer Comparison

Comparables:
ADCT
CRSP
BSLN
IDIA
KURN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Cash from Operating Activities
-CHf29.8m
CAGR 3-Years
N/A
CAGR 5-Years
6%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash from Operating Activities
-$118.7m
CAGR 3-Years
11%
CAGR 5-Years
0%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash from Operating Activities
-$260.4m
CAGR 3-Years
-3%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Cash from Operating Activities
CHf14.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Cash from Operating Activities
-CHf859.1m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Cash from Operating Activities
-CHf8.8m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Santhera Pharmaceuticals Holding AG's Cash from Operating Activities?
Cash from Operating Activities
-29.8m CHF

Based on the financial report for Dec 31, 2022, Santhera Pharmaceuticals Holding AG's Cash from Operating Activities amounts to -29.8m CHF.

What is Santhera Pharmaceuticals Holding AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
6%

Over the last year, the Cash from Operating Activities growth was 20%.